These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8069529)
1. Soluble Fc epsilon RII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII/CD23. Yoshikawa T; Nanba T; Kato H; Hori K; Inamoto T; Kumagai S; Yodoi J Immunomethods; 1994 Feb; 4(1):65-71. PubMed ID: 8069529 [TBL] [Abstract][Full Text] [Related]
2. Soluble CD23 as a sensitive marker for Epstein-Barr virus-related disorders after liver transplantation. Kato H; Inamoto T; Nakamura H; Furuke K; Uemoto S; Tanaka K; Ozawa K; Hori T; Yodoi J Transplantation; 1993 Nov; 56(5):1109-13. PubMed ID: 8249109 [TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of IgE-binding factor/soluble CD23 in bullous pemphigoid. Furukawa F; Kumagai S; Sakamoto Y; Takigawa M; Imamura S J Dermatol Sci; 1994 Apr; 7(2):150-4. PubMed ID: 8060916 [TBL] [Abstract][Full Text] [Related]
4. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis. Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005 [TBL] [Abstract][Full Text] [Related]
5. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines. Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Bansal AS; MacGregor AJ; Pumphrey RS; Silman AJ; Ollier WE; Wilson PB Clin Exp Rheumatol; 1994; 12(3):281-5. PubMed ID: 8070161 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble CD23 in patients with bullous pemphigoid. Maekawa N; Hosokawa H; Soh H; Kasahara M; Izumi H; Yodoi J; Asada Y J Dermatol; 1995 May; 22(5):310-5. PubMed ID: 7673549 [TBL] [Abstract][Full Text] [Related]
8. The effect of omalizumab treatment on the low affinity immunoglobulin E receptor (CD23/fc epsilon RII) in patients with severe allergic asthma. Assayag M; Moshel S; Kohan M; Berkman N Allergy Asthma Proc; 2018 Jan; 39(1):36-42. PubMed ID: 29279058 [TBL] [Abstract][Full Text] [Related]
9. CD23/Fc epsilon RII expression on phytohemagglutinin-A- or phorbol-12myristate-13acetate-Ca(2+)-activated human tonsil T cells. Carini C; Pini C; DiFelice G; Fattorossi A; Fratazzi C Int Arch Allergy Immunol; 1993; 101(1):31-8. PubMed ID: 8499771 [TBL] [Abstract][Full Text] [Related]
10. Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus. Bansal A; Roberts T; Hay EM; Kay R; Pumphrey RS; Wilson PB Clin Exp Immunol; 1992 Sep; 89(3):452-5. PubMed ID: 1387597 [TBL] [Abstract][Full Text] [Related]
11. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. al-Janadi M; al-Wabel A; Raziuddin S Clin Immunol Immunopathol; 1994 Apr; 71(1):33-7. PubMed ID: 8137557 [TBL] [Abstract][Full Text] [Related]
12. Elevation of soluble CD23 in sera from patients with infectious mononucleosis. Hashimoto S; Takei M; Gon Y; Sawada S; Maekawa N; Yodoi J; Takada K; Horie T J Med Virol; 1997 Dec; 53(4):384-7. PubMed ID: 9407387 [TBL] [Abstract][Full Text] [Related]
13. Production and characterization of two murine monoclonal antibodies directed against epitopes exclusive to soluble fragments of Fc epsilon RII/CD23. Ghaderi AA; Stanworth DR Eur J Immunol; 1993 Nov; 23(11):2909-15. PubMed ID: 7693481 [TBL] [Abstract][Full Text] [Related]
14. ICAM-1, soluble-CD23, and interleukin-10 concentrations in serum in renal-transplant recipients with Epstein-Barr virus reactivation. Hornef MW; Bein G; Wilhelm D; Fricke L; Kirchner H Clin Diagn Lab Immunol; 1997 Sep; 4(5):545-9. PubMed ID: 9302203 [TBL] [Abstract][Full Text] [Related]
15. Elevated levels of soluble Fc epsilon RII/CD23 and antibodies to Epstein-Barr virus in patients with Sjögren's syndrome. Suzuki M; Nagata S; Hiramatsu K; Takagi I; Ito H; Kitao S; Ito M; Ohta N; Baba S Acta Otolaryngol Suppl; 1996; 525():108-12. PubMed ID: 8908282 [TBL] [Abstract][Full Text] [Related]
16. Expression, regulation and function of human Fc epsilon RII (CD23) antigen. Sarfati M; Fournier S; Wu CY; Delespesse G Immunol Res; 1992; 11(3-4):260-72. PubMed ID: 1287120 [TBL] [Abstract][Full Text] [Related]
18. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE. Saxon A; Ke Z; Bahati L; Stevens RH J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):333-44. PubMed ID: 1698844 [TBL] [Abstract][Full Text] [Related]
19. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Martinez OM; Villanueva JC; Lawrence-Miyasaki L; Quinn MB; Cox K; Krams SM Transplantation; 1995 Feb; 59(4):519-24. PubMed ID: 7878757 [TBL] [Abstract][Full Text] [Related]
20. Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain. Bossolasco S; Nilsson A; de Milito A; Lazzarin A; Linde A; Cinque P; Chiodi F AIDS; 2001 Jun; 15(9):1109-13. PubMed ID: 11416712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]